+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Melanoma Market and Competitive Landscape - 2020

  • ID: 5023492
  • Report
  • April 2020
  • Region: Global
  • Fore Pharma
1 of 2
The research report Global Melanoma Market and Competitive Landscape - 2020, provides comprehensive insights into the Melanoma pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Melanoma market size and drug sales. It also provides insights into Melanoma epidemiology and late stage pipeline.

This research covers the following: Melanoma treatment options, Melanoma late stage clinical trials pipeline, Melanoma prevalence by countries, Melanoma market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).

Research Scope:
  • Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
  • Melanoma pipeline: Find out drugs in clinical trials for the treatment of Melanoma by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Melanoma epidemiology: Find out the number of patients diagnosed (prevalence) with Melanoma by countries
  • Melanoma drugs: Identify key drugs marketed and prescribed for Melanoma in the US, including trade name, molecule name, and company
  • Melanoma drugs sales: Find out the sales value for Melanoma drugs by countries
  • Melanoma market valuations: Find out the market size for Melanoma drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Melanoma drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Melanoma drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Melanoma market
  • Develop in-depth knowledge of competition and markets
  • Analyze Melanoma drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Melanoma market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Melanoma Treatment Options

2. Melanoma Pipeline Insights
2.1. Melanoma Phase 3 Clinical Trials
2.2. Melanoma Phase 2 Clinical Trials
2.3. Melanoma Phase 1 Clinical Trials

3. Melanoma Epidemiology Analysis by Countries

4. US Melanoma Market Insights
4.1. Marketed Drugs for Melanoma in US
4.2. US Melanoma Market Size & Forecast
4.3. US Melanoma Drugs Sales & Forecast
4.4. US Melanoma Market Share Analysis

5. Germany Melanoma Market Insights
5.1. Marketed Drugs for Melanoma in Germany
5.2. Germany Melanoma Market Size & Forecast
5.3. Germany Melanoma Drugs Sales Forecast
5.4. Germany Melanoma Market Share Analysis

6. France Melanoma Market Insights
6.1. Marketed Drugs for Melanoma in France
6.2. France Melanoma Market Size & Forecast
6.3. France Melanoma Product Sales Forecast
6.4. France Melanoma Market Share Analysis

7. Italy Melanoma Market Insights
7.1. Marketed Drugs for Melanoma in Italy
7.2. Italy Melanoma Market Size & Forecast
7.3. Italy Melanoma Product Sales Forecast
7.4. Italy Melanoma Market Share Analysis

8. Spain Melanoma Market Insights
8.1. Marketed Drugs for Melanoma in Spain
8.2. Spain Melanoma Market Size & Forecast
8.3. Spain Melanoma Product Sales Forecast
8.4. Spain Melanoma Market Share Analysis

9. UK Melanoma Market Insights
9.1. Marketed Drugs for Melanoma in UK
9.2. UK Melanoma Market Size & Forecast
9.3. UK Melanoma Product Sales Forecast
9.4. UK Melanoma Market Share Analysis

10. Europe Melanoma Market Insights
10.1. Europe Melanoma Market Size & Forecast
10.2. Europe Melanoma Product Sales Forecast
10.3. Europe Melanoma Market Share Analysis

11. Japan Melanoma Market Insights
11.1. Marketed Drugs for Melanoma in Japan
11.2. Japan Melanoma Market Size & Forecast
11.3. Japan Melanoma Product Sales Forecast
11.4. Japan Melanoma Market Share Analysis

12. Global Melanoma Market Insights
12.1. Global Melanoma Market Size & Forecast
12.2. Global Melanoma Product Sales Forecast
12.3. Global Melanoma Market Share Analysis

13. Research Methodology

List of Tables
Table 1: Melanoma Phase 3 Clinical Trials, Global, 2020
Table 2: Melanoma Phase 2 Clinical Trials, Global, 2020
Table 3: Melanoma Phase 1 Clinical Trials, Global, 2020
Table 4: Melanoma Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Melanoma in US, 2019
Table 6: US Melanoma Market Size & Forecast ($mn), 2016 - 2024
Table 7: US Melanoma Product Sales ($mn), 2016 - 2024
Table 8: US Melanoma Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Melanoma in Germany, 2019
Table 10: Germany Melanoma Market Size & Forecast ($mn), 2016 - 2024
Table 11: Germany Melanoma Product Sales ($mn), 2016 - 2024
Table 12: Germany Melanoma Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Melanoma in France, 2019
Table 14: France Melanoma Market Size & Forecast ($mn), 2016 - 2024
Table 15: France Melanoma Product Sales ($mn), 2016 - 2024
Table 16: France Melanoma Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Melanoma in Italy, 2019
Table 18: Italy Melanoma Market Size & Forecast ($mn), 2016 - 2024
Table 19: Italy Melanoma Product Sales ($mn), 2016 - 2024
Table 20: Italy Melanoma Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Melanoma in Spain, 2019
Table 22: Spain Melanoma Market Size & Forecast ($mn), 2016 - 2024
Table 23: Spain Melanoma Product Sales ($mn), 2016 - 2024
Table 24: Spain Melanoma Market Events and Trends, 2016 - 2024
Table 25: Marketed Drugs for Melanoma in UK, 2019
Table 26: UK Melanoma Market Size & Forecast ($mn), 2016 - 2024
Table 27: UK Melanoma Product Sales ($mn), 2016 - 2024
Table 28: UK Melanoma Market Events and Trends, 2016 - 2024
Table 29: Europe Melanoma Market Size & Forecast ($mn), 2016 - 2024
Table 30: Europe Melanoma Product Sales ($mn), 2016 - 2024
Table 31: Marketed Drugs for Melanoma in Japan, 2019
Table 32: Japan Melanoma Market Size & Forecast ($mn), 2016 - 2024
Table 33: Japan Melanoma Product Sales ($mn), 2016 - 2024
Table 34: Japan Melanoma Market Events and Trends, 2016 - 2024
Table 35: Global Melanoma Market Size & Forecast ($mn), 2016 - 2024
Table 36: Global Melanoma Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Melanoma Pipeline by Phase (%), Global, 2020
Figure 2: Melanoma Prevalence by Countries, 2016 - 2024
Figure 3: US Melanoma Market Size ($mn), 2016 - 2024
Figure 4: US Melanoma Product Sales ($mn), 2016 - 2024
Figure 5: US Melanoma Market Share by Drugs (%), 2019
Figure 6: US Melanoma Market - Future Market Share (%), 2024
Figure 7: Germany Melanoma Market Size ($mn), 2016 - 2024
Figure 8: Germany Melanoma Product Sales ($mn), 2016 - 2024
Figure 9: Germany Melanoma Market Share by Drugs (%), 2019
Figure 10: Germany Melanoma Market - Future Market Share (%), 2024
Figure 11: France Melanoma Market Size ($mn), 2016 - 2024
Figure 12: France Melanoma Product Sales ($mn), 2016 - 2024
Figure 13: France Melanoma Market Share by Drugs (%), 2019
Figure 14: France Melanoma Market - Future Market Share (%), 2024
Figure 15: Italy Melanoma Market Size ($mn), 2016 - 2024
Figure 16: Italy Melanoma Product Sales ($mn), 2016 - 2024
Figure 17: Italy Melanoma Market Share by Drugs (%), 2019
Figure 18: Italy Melanoma Market - Future Market Share (%), 2024
Figure 19: Spain Melanoma Market Size ($mn), 2016 - 2024
Figure 20: Spain Melanoma Product Sales ($mn), 2016 - 2024
Figure 21: Spain Melanoma Market Share by Drugs (%), 2019
Figure 22: Spain Melanoma Market - Future Market Share (%), 2024
Figure 23: UK Melanoma Market Size ($mn), 2016 - 2024
Figure 24: UK Melanoma Product Sales ($mn), 2016 - 2024
Figure 25: UK Melanoma Market Share by Drugs (%), 2019
Figure 26: UK Melanoma Market - Future Market Share (%), 2024
Figure 27: Europe Melanoma Market Size ($mn), 2016 - 2024
Figure 28: Europe Melanoma Product Sales ($mn), 2016 - 2024
Figure 29: Europe Melanoma Market Share by Drugs (%), 2019
Figure 30: Europe Melanoma Market - Future Market Share (%), 2024
Figure 31: Japan Melanoma Market Size ($mn), 2016 - 2024
Figure 32: Japan Melanoma Product Sales ($mn), 2016 - 2024
Figure 33: Japan Melanoma Market Share by Drugs (%), 2019
Figure 34: Japan Melanoma Market - Future Market Share (%), 2024
Figure 35: Global Melanoma Market Size ($mn), 2016 - 2024
Figure 36: Global Melanoma Product Sales ($mn), 2016 - 2024
Figure 37: Global Melanoma Market Share by Drugs (%), 2019
Figure 38: Global Melanoma Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll